| 17beta-estradiol | decreases expression | ISO | RGD:733156 | 6480464 | Estradiol results in decreased expression of GPD1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733156 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPD1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:1331950 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of GPD1 protein | CTD | PMID:10497882 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1331950 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein] | CTD | PMID:10497882 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733156 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPD1 mRNA | CTD | PMID:20106945 PMID:21998131 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPD1 mRNA | CTD | PMID:22298810 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1331950 | 6480464 | [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein; more ... | CTD | PMID:11101056 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of GPD1 mRNA | CTD | PMID:19162173 |
| aflatoxin B1 | affects expression | ISO | RGD:733156 | 6480464 | Aflatoxin B1 affects the expression of GPD1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | ISO | RGD:733156 | 6480464 | Aflatoxin B1 results in decreased expression of GPD1 mRNA | CTD | PMID:21641981 PMID:22100608 |
| aflatoxin B1 | decreases expression | ISO | RGD:733156 | 6480464 | Aflatoxin B1 results in decreased expression of GPD1 mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1331950 | 6480464 | Tretinoin results in decreased expression of GPD1 mRNA | CTD | PMID:16604517 |
| aluminium atom | multiple interactions | ISO | RGD:733156 | 6480464 | Aluminum results in increased expression of and results in increased activity of GPD1 protein | CTD | PMID:17762189 |
| aluminium(0) | multiple interactions | ISO | RGD:733156 | 6480464 | Aluminum results in increased expression of and results in increased activity of GPD1 protein | CTD | PMID:17762189 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GPD1 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733156 | 6480464 | Benzo(a)pyrene results in decreased expression of GPD1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1331950 | 6480464 | Benzo(a)pyrene results in decreased expression of GPD1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1331950 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GPD1 mRNA] | CTD | PMID:22228805 |
| bezafibrate | increases expression | ISO | RGD:1331950 | 6480464 | Bezafibrate results in increased expression of GPD1 mRNA | CTD | PMID:1976021 |
| bezafibrate | multiple interactions | ISO | RGD:1331950 | 6480464 | Bucladesine promotes the reaction [Bezafibrate results in increased expression of GPD1 mRNA] | CTD | PMID:1976021 |
| bromobenzene | affects binding | EXP | | 6480464 | bromobenzene metabolite binds to GPD1 protein | CTD | PMID:17305373 |
| bucladesine | multiple interactions | ISO | RGD:1331950 | 6480464 | Bucladesine promotes the reaction [Bezafibrate results in increased expression of GPD1 mRNA] | CTD | PMID:1976021 |
| clofibrate | multiple interactions | ISO | RGD:1331950 | 6480464 | PPARA protein affects the reaction [Clofibrate results in increased expression of GPD1 mRNA]; more ... | CTD | PMID:17585979 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of GPD1 mRNA | CTD | PMID:12851107 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of GPD1 protein | CTD | PMID:16470657 |
| cyclosporin A | decreases expression | ISO | RGD:733156 | 6480464 | Cyclosporine results in decreased expression of GPD1 mRNA | CTD | PMID:20106945 |
| dehydroepiandrosterone | increases activity | ISO | RGD:1331950 | 6480464 | Dehydroepiandrosterone results in increased activity of GPD1 protein | CTD | PMID:10497882 |
| dehydroepiandrosterone | multiple interactions | ISO | RGD:1331950 | 6480464 | benz(a)anthracene inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein]; more ... | CTD | PMID:10497882 |
| dexamethasone | multiple interactions | ISO | RGD:1331950 | 6480464 | [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein; more ... | CTD | PMID:11101056 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of GPD1 mRNA | CTD | PMID:21266533 |
| ethanol | decreases expression | ISO | RGD:1331950 | 6480464 | Ethanol results in decreased expression of GPD1 mRNA | CTD | PMID:15513904 |
| fluoxetine | increases expression | EXP | | 6480464 | Fluoxetine results in increased expression of GPD1 mRNA | CTD | PMID:17033635 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of GPD1 gene | CTD | PMID:22079235 |
| furan | affects binding | EXP | | 6480464 | furan binds to GPD1 protein | CTD | PMID:22240984 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with INS1 protein] results in decreased expression of GPD1 mRNA | CTD | PMID:20400526 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of GPD1 mRNA | CTD | PMID:22641619 |
| leflunomide | decreases expression | ISO | RGD:1331950 | 6480464 | leflunomide results in decreased expression of GPD1 mRNA | CTD | PMID:19751817 |
| paracetamol | multiple interactions | ISO | RGD:1331950 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of GPD1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:1331950 | 6480464 | Acetaminophen results in decreased expression of GPD1 protein | CTD | PMID:22939915 |
| paracetamol | decreases expression | ISO | RGD:733156 | 6480464 | Acetaminophen results in decreased expression of GPD1 mRNA | CTD | PMID:21420995 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of GPD1 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of GPD1 mRNA | CTD | PMID:16221955 |
| permethrin | increases expression | EXP | | 6480464 | Permethrin results in increased expression of GPD1 mRNA | CTD | PMID:19017407 |
| pirinixic acid | multiple interactions | ISO | RGD:1331950 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPD1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of GPD1 mRNA | CTD | PMID:19162173 PMID:22484513 |
| pirinixic acid | increases expression | ISO | RGD:1331950 | 6480464 | pirinixic acid results in increased expression of GPD1 mRNA | CTD | PMID:16357043 more ... |
| pirinixic acid | increases expression | ISO | RGD:1331950 | 6480464 | pirinixic acid results in increased expression of GPD1 mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:1331950 | 6480464 | pirinixic acid results in increased expression of GPD1 mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | ISO | RGD:1331950 | 6480464 | pirinixic acid results in increased expression of GPD1 mRNA | CTD | PMID:16357043 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of GPD1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | increases expression | ISO | RGD:1331950 | 6480464 | pirinixic acid results in increased expression of GPD1 mRNA | CTD | PMID:18301758 more ... |
| progesterone | affects expression | ISO | RGD:1331950 | 6480464 | Progesterone affects the expression of GPD1 mRNA | CTD | PMID:17251523 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of GPD1 mRNA | CTD | PMID:19201733 |
| rosiglitazone | increases expression | ISO | RGD:1331950 | 6480464 | rosiglitazone results in increased expression of GPD1 mRNA | CTD | PMID:17245590 |
| tetraphene | multiple interactions | ISO | RGD:1331950 | 6480464 | benz(a)anthracene inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein] | CTD | PMID:10497882 |
| tetraphene | increases activity | ISO | RGD:1331950 | 6480464 | benz(a)anthracene results in increased activity of GPD1 protein | CTD | PMID:10497882 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of GPD1 protein | CTD | PMID:21315101 |
| vancomycin | increases expression | ISO | RGD:1331950 | 6480464 | Vancomycin results in increased expression of GPD1 mRNA | CTD | PMID:18930951 |